ColgatePalmolive (CL) Q3 2025 earnings review
Organic Growth Stalls and Guidance Cut as Volumes Weaken
Colgate-Palmolive's growth trajectory decelerated sharply in Q3, with organic sales growth of just 0.4%, a significant slowdown from 1.8% last quarter and 6.8% a year ago. The weak top-line was driven by a -1.9% decline in organic volumes, masked by +2.3% pricing. Gross margins contracted by 170 basis points to 59.4%, and the key growth engine, Hill's Pet Nutrition, reported a -1.3% organic sales decline. Reflecting these challenges, the company cut its full-year organic sales growth guidance to 1%-2% from the low end of 2%-4% previously, signaling that the difficult operating environment is expected to persist.
🐂 Bull Case
The company demonstrated continued pricing power, with a +2.3% contribution to sales. This ability to raise prices helps offset some inflationary pressure and indicates strong brand equity.
The Europe and Africa/Eurasia segments showed resilience. Europe's operating profit grew 16% YoY, and Africa/Eurasia posted strong organic sales growth of 6.2%, indicating strength in certain markets.
🐻 Bear Case
The slowdown in organic growth to near-zero is alarming and suggests a broad-based weakening of demand. The company has now seen five consecutive quarters of decelerating organic growth.
Hill's Pet Nutrition, a consistent high-growth driver, posted negative organic sales of -1.3% and a steep organic volume decline of -4.2%. This weakness in a key segment is a major concern.
Management lowered the top end of its FY25 organic sales guidance by half (from 4% to 2%), signaling a lack of confidence in a near-term recovery and confirming the negative trends observed in Q3.
⚖️ Verdict: 🔴
Bearish. The sharp deceleration in organic growth and the cut to full-year guidance are significant red flags. The positive pricing narrative is overshadowed by deteriorating volumes and margin compression. Weakness in the critical Hill's Pet Nutrition segment suggests the company's growth algorithm is under pressure.
Key Themes
Organic Volume Collapse Exposes Top-Line Weakness
Organic volume fell -1.9% in the quarter, a sharp decline from -0.2% in Q2. This indicates that the +2.3% pricing growth is masking a significant demand issue. Key segments saw steep volume declines, including Hill's (-4.2% organic volume), Asia Pacific (-3.5%), and Latin America (-1.9%), suggesting widespread consumer resistance to pricing or a general category slowdown.
Hill's Pet Nutrition Stalls, Ending Growth Streak
The company's primary growth engine, Hill's Pet Nutrition, reported a -1.3% decline in organic sales. While management cited an 80-90 basis point headwind from exiting its private label business, the underlying weakness is stark with organic volumes down -4.2%. This reversal from consistent high-single-digit growth in prior years is a major concern for the company's future growth and margin mix.
Gross Margin Compresses as Cost Pressures Persist
GAAP gross margin fell 170 basis points year-over-year to 59.4%, dropping below the 60% threshold. Management cited higher-than-anticipated raw material inflation and the negative impact of lower volumes on factory leverage. The full-year guidance was revised to be 'roughly in line' with the YTD margin of 60.1%, a downgrade from the previous 'roughly flat' outlook (vs 60.5% in FY24), suggesting pressure will continue.
North America Remains a Weak Spot
The North America segment continues to struggle, posting a -0.5% decline in organic sales. Operating profit for the division fell by 8% YoY, and the operating margin contracted by 150 basis points to 19.0%. In the earnings call, management noted that the consumer remains weak and category takeaway in the U.S. was softer than anticipated.
Europe Delivers Profit Growth Despite Slowdown
Europe was a notable bright spot, with operating profit increasing 16% YoY and margins expanding 180 basis points to 26.1%. This performance came despite organic sales growth slowing to 1.2%. The strong profitability suggests effective cost control and a favorable product mix in the region.
Operational Issues Impact Latin America
Management disclosed on the call that a voluntary product replacement for its Colgate Total toothpaste in Latin America negatively impacted results. This adjustment, made after consumer complaints about a new formula, created a 150 basis point drag on the region's organic growth and a 40-50 basis point impact on total company gross margin.
Other KPIs
Profitability weakened across most divisions. Operating profit fell in North America (-8%), Latin America (-8%), Asia Pacific (-6%), and Hill's Pet Nutrition (-1%). Only Europe (+16%) and Africa/Eurasia (+5%) saw increases, highlighting broad-based earnings pressure.
The gross margin has trended down for three consecutive quarters, falling from 60.8% in Q1 to 59.4% in Q3. This steady compression indicates that pricing actions are not fully offsetting raw material inflation, negative FX, and lower fixed cost absorption from declining volumes.
Year-to-date cash flow from operations remains robust at $2.75 billion, only slightly down from $2.84 billion in the prior year period. This stability provides financial flexibility to continue investing in the business and returning capital to shareholders despite the operational challenges.
Guidance
Decelerating. This is a significant reduction from the prior guidance of 'low end of 2% to 4%'. The new guidance implies Q4 organic growth between 0.4% and 1.6% (midpoint 1.0%), confirming the trend of stalled growth is expected to continue.
Slightly lowered. The guidance was revised from 'roughly flat' (vs 60.5% in FY24) to 'roughly in line with year-to-date gross profit margin of 60.1%'. This subtle change confirms that the margin pressures seen in Q3 are expected to prevent a recovery to prior-year levels.
Stable. The company maintained its EPS guidance despite the top-line and margin headwinds. This suggests cost controls, productivity savings, or other below-the-line items are being used to protect the bottom-line forecast.